EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, McKesson's Enterprise Value is $56,190 Mil.
McKesson's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2022 was $4,639 Mil. Therefore, McKesson's EV-to-FCF for today is 12.11.
The historical rank and industry rank for McKesson's EV-to-FCF or its related term are showing as below:
MCK'
s EV-to-FCF Range Over the Past 10 Years
Min: 6.59 Med: 12.34 Max: 28.97
Current: 12.11
During the past 13 years, the highest EV-to-FCF of McKesson was 28.97. The lowest was 6.59. And the median was 12.34.
MCK's EV-to-FCF is ranked better than 68.75% of 48
companies
in the Medical Distribution industry
Industry Median: 18.34
vs MCK: 12.11
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2022-08-10), McKesson's stock price is $354.77.
McKesson's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $9.400. Therefore, McKesson's PE Ratio for today is 37.74.
Competitive Comparison
For the Medical Distribution subindustry, McKesson's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
McKesson EV-to-FCF Distribution
For the Medical Distribution industry and Healthcare sector, McKesson's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where McKesson's EV-to-FCF falls into.
McKesson's current Enterprise Value is $56,190 Mil.
McKesson's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,639 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
McKesson (NYSE:MCK) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
McKesson's share price for today is $354.77.
McKesson's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.400.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
McKesson EV-to-FCF Related Terms
Thank you for viewing the detailed overview of McKesson's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0(0%) Volume: 1,298,723 9:40AM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:MCK has been successfully added to your 
